AneuRX – SOLD (to Medtronic). Bacchus Vascular – SOLD (to Covidien). Nellix – SOLD (to Endologix). Who played a big part in all of these wins? Answer: Gwen Watanabe. In this interview, we’ll learn more about Gwen’s experience with early-stage medical device companies and how she’s using her skills to blaze some trails with Hotspur Technologies, a company that has brought to market 3 innovative endovascular devices.
Link to the interview: http://bit.ly/kSYhot
Link to the interview: http://bit.ly/kSYhot